Market Value3,268,881,624
Total Holdings55
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GOSS / Gossamer Bio, Inc.
NUVB / Nuvation Bio Inc.
JAZZ / Jazz Pharmaceuticals plc
SRPT / Sarepta Therapeutics, Inc.
ALVR / AlloVir, Inc.
THRD / Third Harmonic Bio, Inc.
KROS / Keros Therapeutics, Inc.
KURA / Kura Oncology, Inc. Call
RCKT / Rocket Pharmaceuticals, Inc.
KYTX / Kyverna Therapeutics, Inc.
MORF / Morphic Holding, Inc.
ARVN / Arvinas, Inc.
ALGS / Aligos Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
LENZ / LENZ Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
AVIR / Atea Pharmaceuticals, Inc.
GBIO / Generation Bio Co.
CLDX / Celldex Therapeutics, Inc.
PRME / Prime Medicine, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
PRQR / ProQR Therapeutics N.V.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
VYGR / Voyager Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
PRTA / Prothena Corporation plc
CRNX / Crinetics Pharmaceuticals, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
HOOK / HOOKIPA Pharma Inc.
PCVX / Vaxcyte, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ALEC / Alector, Inc.
OVID / Ovid Therapeutics Inc.
ATRA / Atara Biotherapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
NKTX / Nkarta, Inc.
EWTX / Edgewise Therapeutics, Inc.
REPL / Replimune Group, Inc.
TNGX / Tango Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
NMRA / Neumora Therapeutics, Inc.
KOD / Kodiak Sciences Inc.
KOD / Kodiak Sciences Inc. Call
CRSP / CRISPR Therapeutics AG
ATRA / Atara Biotherapeutics, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
ANAB / AnaptysBio, Inc.
KURA / Kura Oncology, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
TECX / Tectonic Therapeutic, Inc.
NGNE / Neurogene Inc.
RNA / Avidity Biosciences, Inc.
TCRX / TScan Therapeutics, Inc.
ZYME / Zymeworks Inc.
PHVS / Pharvaris N.V.
CRGX / CARGO Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
XNCR / Xencor, Inc.
ITOS / iTeos Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
IMNM / Immunome, Inc.